Roger J P Dawson

Years Active: 2018-2021
Publications (10 Years): 3

Linkster Therapeutics AG

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Linkster Therapeutics AG Oct 01 2019

Switzerland

Chief Executive Officer

Publications

Azadeh Shahsavar, Peter Stohler, Gleb Bourenkov, Iwan Zimmermann, Martin Siegrist, Wolfgang Guba, Emmanuel Pinard, Steffen Sinning, Markus A Seeger, Thomas R Schneider, Roger J P Dawson, Poul Nissen
Structural insights into the inhibition of glycine reuptake. Nature 591 (7851) (2021)
Shoji Maeda, Antoine Koehl, Hugues Matile, Hongli Hu, Daniel Hilger, Gebhard F X Schertler, Aashish Manglik, Georgios Skiniotis, Roger J P Dawson, Brian K Kobilka
Development of an antibody fragment that stabilizes GPCR/G-protein complexes. Nature communications 9 (1) (2018)
Daniel Mattle, Bernd Kuhn, Johannes Aebi, Marc Bedoucha, Demet Kekilli, Nathalie Grozinger, Andre Alker, Markus G Rudolph, Georg Schmid, Gebhard F X Schertler, Michael Hennig, Jörg Standfuss, Roger J P Dawson
Ligand channel in pharmacologically stabilized rhodopsin. Proceedings of the National Academy of Sciences of the United States of America 115 (14) (2018)

Roger J P Dawson.css-eqlu8i{font-size:small;padding-left:4px;}